Premium
Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects? J. Med. Virol. 2020; 92:915‐918
Author(s) -
Gando Alejandro,
Alexay Sofia,
Galán Núñez Juan P.,
Cano Lucía N.,
Diez Roberto A.,
Costa Luis A.
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26879
Subject(s) - medicine , erythropoietin , epoetin alfa , population , intensive care medicine , emergency medicine , environmental health